Clinical Trial Update: Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gabapentin to treat chemotherapy-induced peripheral neuropathy in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Neurotoxicity, Pain | Phase 3 | Status: COMPLETED